King Pharmaceuticals (KG) Misses Q2 EPS by 103c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| KING PHARMACEUTICALS (NASDAQ: KG) | Delayed: 4.29 +0.07 (1.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.22 | 52 Week High | $14.26 | |||
| Open | $4.29 | 52 Week Low | $7.18 | |||
| Day High | $4.29 | P/E | 12.62 | |||
| Day Low | $4.29 | EPS | $0.34 | |||
| Volume | 417 | |||||
